Rating History for Relmada Therapeutics Inc (RLMD) by Leerink Partners
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 1/23/2026 | Marc Goodman | Upgrade | Outperform (Market Perform) |
8.00 (N/A) |
3.96 (4.45) |
12.37% | Details |
 |
|||||||
|
|||||||
